1. Fourth quarter revenue of $1.4 billion was a 1.4 percent increase year-over-year. For the full year of 2022, the company saw $5.2 billion in sales, a 4.7 percent increase year-over-year.
2. Fourth quarter orthopedic sales were $549 million, a 0.4 percent dip compated to the same time in 2021. Knee sales were $234 million, and hip sales were $150 million.
3. Orthopedic sales in 2022 overall reached $2.1 billion, a 2 percent decrease compared to 2021. Full-year knee sales were $899 million, and hip sales were $584 million.
4. Smith+Nephew is implementing a 12-point plan to support 2023 sales, including efforts to “regain momentum” in orthopedics.
“Through the 12-point plan we are focused on addressing these challenges, including improving logistics and updating our demand and supply planning process to bring a deeper level of specificity and collaboration between our operations and commercial teams,” the company’s report said.
5. Smith+Nephew expects to see 2023 revenue increase five percent to six percent.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
